0001014108-22-000043.txt : 20220214 0001014108-22-000043.hdr.sgml : 20220214 20220214153151 ACCESSION NUMBER: 0001014108-22-000043 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ugwumba Chidozie CENTRAL INDEX KEY: 0001835544 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 22630577 MAIL ADDRESS: STREET 1: 158 FILMORE STREET CITY: DENVER STATE: CO ZIP: 80206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BiomX Inc. CENTRAL INDEX KEY: 0001739174 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 EINSTEIN ST., 5TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 BUSINESS PHONE: (972) 72 394 2377 MAIL ADDRESS: STREET 1: 22 EINSTEIN ST., 5TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20180430 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2021-12-31 0 0001739174 BiomX Inc. PHGE 0001835544 Ugwumba Chidozie 609 SW 8TH STREET SUITE 365 BENTONVILLE AR 72712 0 0 1 0 Common Stock 3637846 I By SymBiosis, LLC Warrants to purchase Common Stock 5 2022-01-28 2027-01-28 Common Stock 1875000 I By SymBiosis, LLC The shares are directly held by SymBiosis, LLC. Previously, the beneficial owner of these shares was Thomas Layton Walton, by virtue of his sole voting power and dispositive power through SymBiosis, LLC. Although SymBiosis, LLC continues to hold these shares directly and Thomas Layton Walton continues to hold his pecuniary interest in these shares, the reporting person now exercises sole voting power and dispositive power through SymBiosis, LLC through a transition of that power to the reporting person (and not through a sale or other transfer of these shares). These shares beneficially owned by the reporting person include (i) 1,137,846 shares of common stock already owned by SymBiosis, LLC prior to July 28, 2021, (ii) 2,500,000 shares of common stock owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021 and (iii) warrants (to purchase 1,875,000 shares of common stock) owned by SymBiosis, LLC that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021. /s/ Chidozie Ugsumba 2022-02-13